Patents by Inventor Sang O Pan

Sang O Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10925914
    Abstract: The present invention provides a health functional food composition and a pharmaceutical composition for preventing and alleviating depression, both compositions using an extract of Vaccinium bracteatum Thunb. fruits, which are Korean natural resources, so as to be safely usable without toxicity and side effects.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: February 23, 2021
    Assignee: JEONNAM BIOINDUSTRY FOUNDATION
    Inventors: Chul Yung Choi, Jae Yong Kim, Gyu Ok Lee, Ja Won Shin, Hu Won Kang, Ara Jo, Hak Joon Choi, Sang O Pan, Sung Yoon Park, Hyo Jeong Yun, So Jeong Im, Mi Ri Kim, Yong Uk Kim, Dool-Ri Oh, Eun Jin Choi, Yu Jin Kim, Dong Hyuck Bae, KyoNyeo Oh, Myung-A Jung, Ji Ae Hong, Hyun Mi Lee, Rack Seon Seong
  • Publication number: 20200121749
    Abstract: The present invention provides a pharmaceutical composition for prevention or treatment of a stress disease and depression, the pharmaceutical composition be safely useable without toxicity and side effects by using an extract of leaves of Vaccinium bracteatum Thunb., which is natural resource of Korea, so that the reduction of manufacturing and production costs and the import substitution and export effects can be expected through the replacement of a raw material for preparation with a plant inhabiting in nature.
    Type: Application
    Filed: February 7, 2018
    Publication date: April 23, 2020
    Inventors: Chul Yung CHOI, Dool Ri OH, Yu Jin KIM, Eun Jin CHOI, Hyun Mi LEE, Dong Hyuck BAE, Kyo Nyeo OH, Myung-A JUNG, Ji Ae HONG, Kwang Su KIM, Hu Won KANG, Jae Yong KIM, Sang O PAN, Sung Yoon PARK, Rack Seon SEONG
  • Publication number: 20190381123
    Abstract: The present invention provides a health functional food composition and a pharmaceutical composition for preventing and alleviating depression, both compositions using an extract of Vaccinium bracteatum Thunb. fruits, which are Korean natural resources, so as to be safely usable without toxicity and side effects.
    Type: Application
    Filed: November 8, 2017
    Publication date: December 19, 2019
    Inventors: Chul Yung CHOI, Jae Yong KIM, Gyu Ok LEE, Ja Won SHIN, Hu Won KANG, Ara JO, Hak Joon CHOI, Sang O PAN, Sung Yoon PARK, Hyo Jeong YUN, So Jeong IM, Mi Ri KIM, Yong Uk KIM, Dool-Ri OH, Eun Jin CHOI, Yu Jin KIM, Dong Hyuck BAE, KyoNyeo OH, Myung-A JUNG, Ji Ae HONG, Hyun Mi LEE, Rack Seon SEONG
  • Patent number: 10328110
    Abstract: The present invention relates to a composition for promoting osteoblast or cartilage cell differentiation. More particularly, the present invention relates to a composition, which includes stauntonia hexaphylla leaf extract that may be safely used without toxicity and side effects by using a natural ingredient, for promoting bone (tissue) formation to be used for suppressing and treating bone and cartilage tissue damage. A pharmaceutical composition including the stauntonia hexaphylla leaf extract according to the present invention as an active ingredient may be used as a medicine for periodontitis or osteoporosis to treat or prevent periodontitis or osteoporosis.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: June 25, 2019
    Assignees: JEONNAM BIOINDUSTRY FOUNDATION, YUNGJIN PHARMACEUTICAL CO., LTD.
    Inventors: Chul Yung Choi, Sang O Pan, Hee Jin Seol, Gyu Ok Lee, Wook Jin Jang, Hee Sook Kim, Jae Yong Kim, HuWon Kang, Dong Wook Lee, Sun Oh Kim, Jae Gap Kim, JoonYung Park
  • Publication number: 20160193265
    Abstract: Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.
    Type: Application
    Filed: February 1, 2016
    Publication date: July 7, 2016
    Applicants: Jeonnam Bioindustry Foundation, YUNGJIN PHARM.CO., LTD.
    Inventors: Chul Yung CHOI, Sang O PAN, Hee Jin SEOL, Gyu Ok LEE, Ka Hyon PARK, Hee Sook KIM, Wook Jin JANG, Hyun KIM, Dong Wook LEE, Sun Oh KIM, Jae Gap KIM
  • Patent number: 9370542
    Abstract: Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: June 21, 2016
    Assignees: JEONNAM BIOINDUSTRY FOUNDATION, YUNGJIN PHARM.CO., LTD.
    Inventors: Chul Yung Choi, Sang O Pan, Hee Jin Seol, Gyu Ok Lee, Ka Hyon Park, Hee Sook Kim, Wook Jin Jang, Hyun Kim, Dong Wook Lee, Sun Oh Kim, Jae Gap Kim
  • Publication number: 20160113979
    Abstract: The present invention relates to a composition for promoting osteoblast or cartilage cell differentiation. More particularly, the present invention relates to a composition, which includes stauntonia hexaphylla leaf extract that may be safely used without toxicity and side effects by using a natural ingredient, for promoting bone (tissue) formation to be used for suppressing and treating bone and cartilage tissue damage. A pharmaceutical composition including the stauntonia hexaphylla leaf extract according to the present invention as an active ingredient may be used as a medicine for periodontitis or osteoporosis to treat or prevent periodontitis or osteoporosis.
    Type: Application
    Filed: April 29, 2014
    Publication date: April 28, 2016
    Applicants: YUNGJIN PHARMACEUTICAL CO., LTD., Jeonnam Bioindustry Foundation
    Inventors: Chul Yung CHOI, Sang O PAN, Hee Jin SEOL, Gyu Ok LEE, Wook Jin JANG, Hee Sook KIM, Jae Yong KIM, HuWon KANG, Dong Wook LEE, Sun Oh KIM, Jae Gap KIM, JoonYung PARK
  • Publication number: 20140205691
    Abstract: Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.
    Type: Application
    Filed: May 16, 2012
    Publication date: July 24, 2014
    Applicants: YUNGJIN PHARM.CO., LTD., JEONNAM BIOINDUSTRY FOUNDATION
    Inventors: Chul Yung Choi, Sang O Pan, Hee Jin Seol, Gyu Ok Lee, Ka Hyon Park, Hee Sook Kim, Wook Jin Jang, Hyun Kim, Dong Wook Lee, Sun Oh Kim, Jae Gap Kim